Diabetes in GCC Region Industry Platform
This platform provides a brief description of the diabetes epidemiological situation in Gulf Cooperation Council (also known as the GCC and comprising United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and Bahrain).
Despite dedicated nationwide efforts to raise awareness against the harmful effects of fast-food consumption and sedentary lifestyle, the Arab population continues to struggle with an increased risk for metabolic disorders. The International Diabetes Federation (IDF) has reported that GCC countries have one of the highest prevalence of diabetes and obesity in the world, given the sedentary lifestyles and increased consumption of foods that are high in calories and sugar.
Of the 149,600 deaths in the GCC during 2020, nearly 73% were due to noncommunicable diseases (NCDs). In this report, we reviewed genetic background of diabetes among Arab populations, analyzed healthcare market and key market players that offer services to diabetes patients.
Diabetes in GCC Region Industry is a platform where advanced biotechnology intersects with revolutionary solutions for diabetes, effortlessly linking you with prominent investors, respected institutions, and forward-thinking research and development hubs.
From groundbreaking therapies and cutting-edge wearable technologies to AI-powered monitoring and precision medicine for diabetes, the Diabetes Platform is reshaping the landscape of diabetes care in the GCC region.
Diabetes in the UAE Industry Platform
This platform into an analysis of the diabetes market and the utilization of advanced technology in managing individuals with diabetes, with a specific focus on the UAE. Despite extensive national campaigns aimed at raising awareness about the detrimental effects of fast-food consumption and sedentary lifestyles, the Arab population still faces a heightened risk of metabolic disorders.
AI in BioMed
A comprehensive platform AI in BioMed sheds light on the developing nexus between artificial intelligence and biotechnology. Access to ground-breaking AI frameworks, powerful investors, business leaders, well-known organizations, and state-of-the-art research facilities are all available through this complex center, which addresses a range of subjects from biomarkers and drug discovery to neurotech and space medicine.
Global AI in Drug Discovery Platform
Analytics platform to explore how AI is revolutionizing drug discovery globally. You will gain access to our interactive databases for AI in drug discovery, containing filterable, searchable, interactive mindmaps and profiles of 800 companies, 1,900 investors, 90 corporations, 50 hubs, and 100 leaders.
Diabetes Industry Global Dashboard
Aging Analytics Agensy has engineered an advanced analytical dashboard capable of defining, analysing, and predicting trends in the Diabetes industry, and the DeepTech technologies powering it.
The Dashboard provides professional users with comparative analytical capabilities, including interactive, searchable and filterable databases of companies, investors and funding rounds, as well as Automated SWOT Analysis and AI-Driven Smart-Matching facilities.
Aging Analytics Agency – Powered by Deep Knowledge Group
Aging Analytics Agency is a subsidiary of Deep Knowledge Group, a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more.